Ledger.Open graph →
SEC Form D · Amendment · filed September 19, 2019

Emergo Therapeutics, Inc

Offering
$12.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jennifer A. Lawton · Boulder, COExecPeter J. Klein · New York, NYDirectorPaul A. Berberian · Boulder, COExec · DirectorKevin D. King · New York, NYDirectorMary Kopczynski · New York, NYDirectorAlex F. Knowles · Los Angeles, CAExec · DirectorFrederick M. Lax · Malibu, CAExecBarrett C. Gouger · Nixa, MODirectorKip C. Glass · Nixa, MODirectorCurt C. Hargis · Nixa, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗